Ifp Advisors, Inc Precigen, Inc. Transaction History
Ifp Advisors, Inc
- $3.28 Billion
- Q2 2025
A detailed history of Ifp Advisors, Inc transactions in Precigen, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 13 shares of PGEN stock, worth $52. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13
Previous 5
160.0%
Holding current value
$52
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding PGEN
# of Institutions
165Shares Held
175MCall Options Held
511KPut Options Held
1M-
Third Security, LLC83.5MShares$334 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD26.5MShares$106 Million4.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.3MShares$45.1 Million0.03% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$41 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.07MShares$36.3 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $833M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...